Novedades sobre el cáncer femenino: Cáncer de ovario. De IO a PARP

与时俱进的女性癌症治疗：卵巢癌 - 从 IO 到 PARP

The Evolution of Estrogen in Contraception—From E1 to E4

Expanding Choices in Combined Hormonal Contraceptives—The Contraceptive Patch

Riding the Wave of Change in Managing Vulvovaginal Candidiasis—Adapting to a New Era

Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP

Individualizing Treatment Strategies for Endometriosis

The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert Dialogue

Expanding Choices in Combined Hormonal Contraceptives: The Creeping Pearl Index

Hemolytic Disease of the Fetus and Newborn: Cutting Edge Strategies for Diagnosis and Management

Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability

New Directions in the Management of Uterine Fibroids

Clinical & Practical Perspectives in Menopause Management

Advances in Cervical Cancer Screening

Expanding Choices in Combined Hormonal Contraceptives—Seeing Beyond LARCs

New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)

Expanding Contraceptive Choices Beyond Long-Acting Reversible Methods

Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma

Strategie di consulenza sulla NIPT: Prendere in considerazione il test, comunicare i risultati

NIPT Counseling Strategies: Considering the Test, Reporting the Results